Published in J Exp Med on July 27, 2009
The regulation of IL-10 production by immune cells. Nat Rev Immunol (2010) 9.18
Differentiation stage determines pathologic and protective allergen-specific CD4+ T-cell outcomes during specific immunotherapy. J Allergy Clin Immunol (2011) 2.04
Immune regulation of cancer. J Clin Oncol (2010) 1.99
Complement regulator CD46 temporally regulates cytokine production by conventional and unconventional T cells. Nat Immunol (2010) 1.67
IL-27 promotes IL-10 production by effector Th1 CD4+ T cells: a critical mechanism for protection from severe immunopathology during malaria infection. J Immunol (2011) 1.56
Targeting self- and foreign antigens to dendritic cells via DC-ASGPR generates IL-10-producing suppressive CD4+ T cells. J Exp Med (2012) 1.50
Pathogenic T cells have a paradoxical protective effect in murine autoimmune diabetes by boosting Tregs. J Clin Invest (2010) 1.40
Regulation of adaptive immunity; the role of interleukin-10. Front Immunol (2013) 1.38
Nanoparticle-mediated codelivery of myelin antigen and a tolerogenic small molecule suppresses experimental autoimmune encephalomyelitis. Proc Natl Acad Sci U S A (2012) 1.31
Sequential transcriptional changes dictate safe and effective antigen-specific immunotherapy. Nat Commun (2014) 1.15
Quantitative events determine the differentiation and function of helper T cells. Nat Immunol (2011) 1.13
A systems model for immune cell interactions unravels the mechanism of inflammation in human skin. PLoS Comput Biol (2010) 1.07
Specific gut commensal flora locally alters T cell tuning to endogenous ligands. Immunity (2013) 1.07
TGF-β signaling via Smad4 drives IL-10 production in effector Th1 cells and reduces T-cell trafficking in EAE. Eur J Immunol (2011) 1.06
HIV controllers maintain a population of highly efficient Th1 effector cells in contrast to patients treated in the long term. J Virol (2012) 1.04
Genetic susceptibility to systemic lupus erythematosus protects against cerebral malaria in mice. Proc Natl Acad Sci U S A (2010) 1.00
IL-10-producing Th1 cells and disease progression are regulated by distinct CD11c⁺ cell populations during visceral leishmaniasis. PLoS Pathog (2012) 1.00
Antigenic strength controls the generation of antigen-specific IL-10-secreting T regulatory cells. Eur J Immunol (2010) 0.98
Quantifying crosstalk among interferon-γ, interleukin-12, and tumor necrosis factor signaling pathways within a TH1 cell model. Sci Signal (2012) 0.97
Role of dendritic cell maturity/costimulation for generation, homeostasis, and suppressive activity of regulatory T cells. Front Immunol (2011) 0.96
T(H)1, T(H)2, and T(H)17 cells instruct monocytes to differentiate into specialized dendritic cell subsets. Blood (2011) 0.95
T-cell responses induced by allergen-specific immunotherapy. Clin Exp Immunol (2010) 0.94
Lack of endogenous IL-10 enhances production of proinflammatory cytokines and leads to Brucella abortus clearance in mice. PLoS One (2013) 0.90
TGF-beta enhances effector Th1 cell activation but promotes self-regulation via IL-10. J Immunol (2010) 0.89
Isolation and characterization of human interleukin-10-secreting T cells from peripheral blood. Hum Immunol (2010) 0.86
Dendritic cells: cellular mediators for immunological tolerance. Clin Dev Immunol (2013) 0.86
Combination peptide immunotherapy based on T-cell epitope mapping reduces allergen-specific IgE and eosinophilia in allergic airway inflammation. Immunology (2013) 0.86
Immunology: A tolerant approach. Nature (2014) 0.85
Tolerogenic dendritic cells and their applications in transplantation. Cell Mol Immunol (2014) 0.84
Effector Phenotype of Plasmodium falciparum-Specific CD4+ T Cells Is Influenced by Both Age and Transmission Intensity in Naturally Exposed Populations. J Infect Dis (2015) 0.83
Selection of epitopes from self-antigens for eliciting Th2 or Th1 activity in the treatment of autoimmune disease or cancer. Semin Immunopathol (2016) 0.83
Glycogen synthase kinase-3 controls IL-10 expression in CD4(+) effector T-cell subsets through epigenetic modification of the IL-10 promoter. Eur J Immunol (2015) 0.82
T-cell responses to the DBLα-tag, a short semi-conserved region of the Plasmodium falciparum membrane erythrocyte protein 1. PLoS One (2012) 0.81
Preclinical development and first-in-human study of ATX-MS-1467 for immunotherapy of MS. Neurol Neuroimmunol Neuroinflamm (2015) 0.80
Allergens are not pathogens: why immunization against allergy differs from vaccination against infectious diseases. Hum Vaccin Immunother (2013) 0.79
Peptide immunotherapy for childhood allergy - addressing translational challenges. Clin Transl Allergy (2011) 0.78
TNF-alpha-treated DC exacerbates disease in a murine tumor metastasis model. Cancer Immunol Immunother (2010) 0.78
Protein kinase C theta is required for efficient induction of IL-10-secreting T cells. PLoS One (2017) 0.77
CD46 Activation Regulates miR-150-Mediated Control of GLUT1 Expression and Cytokine Secretion in Human CD4+ T Cells. J Immunol (2016) 0.77
Ctla-4 modulates the differentiation of inducible Foxp3+ Treg cells but IL-10 mediates their function in experimental autoimmune encephalomyelitis. PLoS One (2014) 0.77
Extra-thymically induced T regulatory cell subsets: the optimal target for antigen-specific immunotherapy. Immunology (2015) 0.77
Induction of CD4(+) Regulatory and Polarized Effector/helper T Cells by Dendritic Cells. Immune Netw (2016) 0.77
T cell responses in the central nervous system. Nat Rev Immunol (2017) 0.76
Autoimmunity: Antigen-specific immunotherapy. Nature (2016) 0.76
IL-10: A Multifunctional Cytokine in Viral Infections. J Immunol Res (2017) 0.75
Myeloid-derived suppressor cells mediate tolerance induction in autoimmune disease. Immunology (2017) 0.75
Bacterial Manipulation of NK Cell Regulatory Activity Increases Susceptibility to Listeria monocytogenes Infection. PLoS Pathog (2016) 0.75
Ontogeny and localization of the cells produce IL-2 in healthy animals. Cytokine (2013) 0.75
Increased Endovascular Staphylococcus aureus Inoculum Is the Link Between Elevated Serum Interleukin 10 Concentrations and Mortality in Patients With Bacteremia. Clin Infect Dis (2017) 0.75
Immunologic self-tolerance maintained by activated T cells expressing IL-2 receptor alpha-chains (CD25). Breakdown of a single mechanism of self-tolerance causes various autoimmune diseases. J Immunol (1995) 29.42
Interleukin-10 and the interleukin-10 receptor. Annu Rev Immunol (2001) 25.63
An essential role for interleukin 10 in the function of regulatory T cells that inhibit intestinal inflammation. J Exp Med (1999) 10.67
Interleukin-23 drives innate and T cell-mediated intestinal inflammation. J Exp Med (2006) 7.76
B cells regulate autoimmunity by provision of IL-10. Nat Immunol (2002) 7.30
Visualization of peptide-specific T cell immunity and peripheral tolerance induction in vivo. Immunity (1994) 7.22
Dendritic cells produce IL-12 and direct the development of Th1 cells from naive CD4+ T cells. J Immunol (1995) 6.09
Interleukin-10-secreting type 1 regulatory T cells in rodents and humans. Immunol Rev (2006) 6.08
High level IL-12 production by murine dendritic cells: upregulation via MHC class II and CD40 molecules and downregulation by IL-4 and IL-10. J Exp Med (1996) 5.29
Suppressor T cells generated by oral tolerization to myelin basic protein suppress both in vitro and in vivo immune responses by the release of transforming growth factor beta after antigen-specific triggering. Proc Natl Acad Sci U S A (1992) 4.94
CD4(+)CD25(-)Foxp3(-) Th1 cells are the source of IL-10-mediated immune suppression in chronic cutaneous leishmaniasis. J Exp Med (2007) 4.66
Identification of an IL-17-producing NK1.1(neg) iNKT cell population involved in airway neutrophilia. J Exp Med (2007) 4.47
Conventional T-bet(+)Foxp3(-) Th1 cells are the major source of host-protective regulatory IL-10 during intracellular protozoan infection. J Exp Med (2007) 4.47
Prevention of arthritis by interleukin 10-producing B cells. J Exp Med (2003) 4.27
Transcriptional mechanisms underlying lymphocyte tolerance. Cell (2002) 4.04
Maturation stages of mouse dendritic cells in growth factor-dependent long-term cultures. J Exp Med (1997) 4.04
Egr-2 and Egr-3 are negative regulators of T cell activation. Nat Immunol (2005) 3.74
IL-10-producing and naturally occurring CD4+ Tregs: limiting collateral damage. J Clin Invest (2004) 3.69
T(H)1 cells control themselves by producing interleukin-10. Nat Rev Immunol (2007) 3.65
Peripheral deletion of antigen-reactive T cells in oral tolerance. Nature (1995) 3.46
IL-10-secreting regulatory T cells do not express Foxp3 but have comparable regulatory function to naturally occurring CD4+CD25+ regulatory T cells. J Immunol (2004) 3.46
Human CD4(+)CD25(+) regulatory, contact-dependent T cells induce interleukin 10-producing, contact-independent type 1-like regulatory T cells [corrected]. J Exp Med (2002) 3.31
Interleukin-10 induces a long-term antigen-specific anergic state in human CD4+ T cells. J Exp Med (1996) 3.30
Interleukin-12 is produced by dendritic cells and mediates T helper 1 development as well as interferon-gamma production by T helper 1 cells. Eur J Immunol (1996) 3.24
Low avidity recognition of self-antigen by T cells permits escape from central tolerance. Immunity (1995) 3.18
T cell deletion in high antigen dose therapy of autoimmune encephalomyelitis. Science (1994) 3.00
Down-regulation of T cell receptors on self-reactive T cells as a novel mechanism for extrathymic tolerance induction. Cell (1991) 2.83
Effect of interleukin-10 on dendritic cell maturation and function. Eur J Immunol (1997) 2.81
Differentiation of Tr1 cells by immature dendritic cells requires IL-10 but not CD25+CD4+ Tr cells. Blood (2004) 2.76
Interleukin-10 production by effector T cells: Th1 cells show self control. J Exp Med (2007) 2.18
Nasal administration of glutamate decarboxylase (GAD65) peptides induces Th2 responses and prevents murine insulin-dependent diabetes. J Exp Med (1996) 2.06
Role for IL-10 in suppression mediated by peptide-induced regulatory T cells in vivo. J Immunol (2003) 1.91
Expression of ICOS in vivo defines CD4+ effector T cells with high inflammatory potential and a strong bias for secretion of interleukin 10. J Exp Med (2003) 1.89
Intravenous injection of soluble antigen induces thymic and peripheral T-cells apoptosis. Proc Natl Acad Sci U S A (1996) 1.85
Inhibition of experimental autoimmune encephalomyelitis by inhalation but not oral administration of the encephalitogenic peptide: influence of MHC binding affinity. Int Immunol (1993) 1.82
Peptide-induced T cell regulation of experimental autoimmune encephalomyelitis: a role for IL-10. Int Immunol (1999) 1.78
Inhibition of T cell and antibody responses to house dust mite allergen by inhalation of the dominant T cell epitope in naive and sensitized mice. J Exp Med (1993) 1.71
Selective development of T helper (Th)2 cells induced by continuous administration of low dose soluble proteins to normal and beta(2)-microglobulin-deficient BALB/c mice. J Exp Med (1996) 1.61
Regulatory role of T cells producing both interferon gamma and interleukin 10 in persistent infection. J Exp Med (2001) 1.57
Tyk2 negatively regulates adaptive Th1 immunity by mediating IL-10 signaling and promoting IFN-gamma-dependent IL-10 reactivation. J Immunol (2006) 1.53
Glucocorticoids down-regulate dendritic cell function in vitro and in vivo. Eur J Immunol (1995) 1.46
Identification and characterization of IL-10/IFN-gamma-producing effector-like T cells with regulatory function in human blood. J Exp Med (2009) 1.41
Early growth response gene-2, a zinc-finger transcription factor, is required for full induction of clonal anergy in CD4+ T cells. J Immunol (2004) 1.41
CD25+ CD4+ T cells compete with naive CD4+ T cells for IL-2 and exploit it for the induction of IL-10 production. Int Immunol (2005) 1.40
Early growth response gene 2 (Egr-2) controls the self-tolerance of T cells and prevents the development of lupuslike autoimmune disease. J Exp Med (2008) 1.38
IL-12 induces human T cells secreting IL-10 with IFN-gamma. J Immunol (1996) 1.32
Immunoregulatory role of IL-10 during superantigen-induced hyporesponsiveness in vivo. J Immunol (1997) 1.29
IL-12 synergizes with IL-2 and other stimuli in inducing IL-10 production by human T cells. J Immunol (1996) 1.27
Inducible costimulator-dependent IL-10 production by regulatory T cells specific for self-antigen. Proc Natl Acad Sci U S A (2004) 1.27
Mucosal tolerance and suppression of collagen-induced arthritis (CIA) induced by nasal inhalation of synthetic peptide 184-198 of bovine type II collagen (CII) expressing a dominant T cell epitope. Clin Exp Immunol (1996) 1.27
Prevention of experimental myasthenia gravis by nasal administration of synthetic acetylcholine receptor T epitope sequences. J Clin Invest (1997) 1.23
Activation of MAP kinase p38 is critical for the cell-cycle-controlled suppressor function of regulatory T cells. Blood (2007) 1.10
IL-10 is essential for disease protection following intranasal peptide administration in the C57BL/6 model of EAE. J Neuroimmunol (2006) 1.09
Persistent antigenic stimulation alters the transcription program in T cells, resulting in antigen-specific tolerance. Eur J Immunol (2006) 1.07
Altered antigen receptor signaling in anergic T cells from self-tolerant T-cell receptor beta-chain transgenic mice. Proc Natl Acad Sci U S A (1991) 1.04
Antigen-induced IL-10+ regulatory T cells are independent of CD25+ regulatory cells for their growth, differentiation, and function. J Immunol (2006) 1.02
IL-2 overcomes the unresponsiveness but fails to reverse the regulatory function of antigen-induced T regulatory cells. J Immunol (2005) 0.97
Differences between responses of naive and activated T cells to anergy induction. J Immunol (1998) 0.92
Retracted Regulation of the maintenance of peripheral T-cell anergy by TAB1-mediated p38 alpha activation. Mol Cell Biol (2004) 0.92
B7H1-Ig fusion protein activates the CD4+ IFN-gamma receptor+ type 1 T regulatory subset through IFN-gamma-secreting Th1 cells. J Immunol (2006) 0.88
IL-2 activation of STAT5 enhances production of IL-10 from human cytotoxic regulatory T cells, HOZOT. Exp Hematol (2007) 0.87
Naive T cells are resistant to anergy induction by anti-CD3 antibodies. J Immunol (2004) 0.87
Negative feedback mechanism suppresses interleukin-12 production by antigen-presenting cells interacting with T helper 2 cells. Eur J Immunol (1996) 0.84
Immune responses in healthy and allergic individuals are characterized by a fine balance between allergen-specific T regulatory 1 and T helper 2 cells. J Exp Med (2004) 3.83
IL-10-secreting regulatory T cells do not express Foxp3 but have comparable regulatory function to naturally occurring CD4+CD25+ regulatory T cells. J Immunol (2004) 3.46
Cutting edge: Th1 cells facilitate the entry of Th17 cells to the central nervous system during experimental autoimmune encephalomyelitis. J Immunol (2008) 3.11
Peptide-based therapeutic vaccines for allergic and autoimmune diseases. Nat Med (2005) 2.27
Mechanisms of immune suppression by interleukin-10 and transforming growth factor-beta: the role of T regulatory cells. Immunology (2006) 2.03
Role for IL-10 in suppression mediated by peptide-induced regulatory T cells in vivo. J Immunol (2003) 1.91
Destructive processing by asparagine endopeptidase limits presentation of a dominant T cell epitope in MBP. Nat Immunol (2002) 1.61
Ectopic expression of neural autoantigen in mouse liver suppresses experimental autoimmune neuroinflammation by inducing antigen-specific Tregs. J Clin Invest (2008) 1.44
Influence of a dominant cryptic epitope on autoimmune T cell tolerance. Nat Immunol (2002) 1.41
Antigen-specific immunotherapy of autoimmune and allergic diseases. Curr Opin Immunol (2010) 1.39
Early growth response gene 2 (Egr-2) controls the self-tolerance of T cells and prevents the development of lupuslike autoimmune disease. J Exp Med (2008) 1.38
Regulation of adaptive immunity; the role of interleukin-10. Front Immunol (2013) 1.38
Comment on "Expression of Helios, an Ikaros transcription factor family member, differentiates thymic-derived from peripherally induced Foxp3+ T regulatory cells". J Immunol (2010) 1.27
T-bet, a Th1 transcription factor regulates the expression of Tim-3. Eur J Immunol (2010) 1.21
CD4+ T cells pass through an effector phase during the process of in vivo tolerance induction. J Immunol (2003) 1.19
Loss of CTL function among high-avidity tumor-specific CD8+ T cells following tumor infiltration. Cancer Res (2008) 1.19
Prevention of both direct and cross-priming of antitumor CD8+ T-cell responses following overproduction of prostaglandin E2 by tumor cells in vivo. Cancer Res (2008) 1.10
Selection and fine-tuning of the autoimmune T-cell repertoire. Nat Rev Immunol (2002) 1.10
Regulatory CD4+ T cells and the control of autoimmune disease. Curr Opin Immunol (2004) 1.10
IL-10 is essential for disease protection following intranasal peptide administration in the C57BL/6 model of EAE. J Neuroimmunol (2006) 1.09
Persistent antigenic stimulation alters the transcription program in T cells, resulting in antigen-specific tolerance. Eur J Immunol (2006) 1.07
The location of NuoL and NuoM subunits in the membrane domain of the Escherichia coli complex I: implications for the mechanism of proton pumping. J Biol Chem (2003) 1.05
Antigen-induced IL-10+ regulatory T cells are independent of CD25+ regulatory cells for their growth, differentiation, and function. J Immunol (2006) 1.02
Human mesenchymal stem cells infiltrate the spinal cord, reduce demyelination, and localize to white matter lesions in experimental autoimmune encephalomyelitis. J Neuropathol Exp Neurol (2010) 0.99
Single particle analysis confirms distal location of subunits NuoL and NuoM in Escherichia coli complex I. J Struct Biol (2007) 0.99
Antigenic strength controls the generation of antigen-specific IL-10-secreting T regulatory cells. Eur J Immunol (2010) 0.98
IL-2 overcomes the unresponsiveness but fails to reverse the regulatory function of antigen-induced T regulatory cells. J Immunol (2005) 0.97
Enhanced selection of FoxP3+ T-regulatory cells protects CTLA-4-deficient mice from CNS autoimmune disease. Proc Natl Acad Sci U S A (2009) 0.96
Peptides containing a dominant T-cell epitope from red cell band 3 have in vivo immunomodulatory properties in NZB mice with autoimmune hemolytic anemia. Blood (2003) 0.96
CTLA-4 controls the thymic development of both conventional and regulatory T cells through modulation of the TCR repertoire. Proc Natl Acad Sci U S A (2012) 0.95
CD4+ T-cell epitopes associated with antibody responses after intravenously and subcutaneously applied human FVIII in humanized hemophilic E17 HLA-DRB1*1501 mice. Blood (2012) 0.94
Ly6C supports preferential homing of central memory CD8+ T cells into lymph nodes. Eur J Immunol (2011) 0.91
Modification of the FoxP3 transcription factor principally affects inducible T regulatory cells in a model of experimental autoimmune encephalomyelitis. PLoS One (2013) 0.89
T regulatory cells and allergy. Microbes Infect (2005) 0.89
Intranasal peptide-induced peripheral tolerance: the role of IL-10 in regulatory T cell function within the context of experimental autoimmune encephalomyelitis. Vet Immunol Immunopathol (2002) 0.88
T regulatory cells in allergy and health: a question of allergen specificity and balance. Int Arch Allergy Immunol (2004) 0.87
The role of intercellular adhesion molecule-1/LFA-1 interactions in the generation of tumor-specific CD8+ T cell responses. J Immunol (2005) 0.87
Differential activation of signal transducer and activator of transcription (STAT)3 and STAT5 and induction of suppressors of cytokine signalling in T(h)1 and T(h)2 cells. Int Immunol (2003) 0.87
The direct synthesis of hydrogen peroxide using platinum-promoted gold-palladium catalysts. Angew Chem Int Ed Engl (2014) 0.86
Isolation and characterization of human interleukin-10-secreting T cells from peripheral blood. Hum Immunol (2010) 0.86
Effects of the nanostructuring of gold films upon their thermal stability. ACS Nano (2010) 0.86
IL-10 suppresses CD2-mediated T cell activation via SHP-1. Mol Immunol (2008) 0.85
The effect of grafting zirconia and ceria onto alumina as a support for silicotungstic acid for the catalytic dehydration of glycerol to acrolein. Chemistry (2014) 0.84
Synthesis of stable ligand-free gold-palladium nanoparticles using a simple excess anion method. ACS Nano (2012) 0.84
CD86 has sustained costimulatory effects on CD8 T cells. J Immunol (2007) 0.82
Activation thresholds determine susceptibility to peptide-induced tolerance in a heterogeneous myelin-reactive T cell repertoire. J Neuroimmunol (2004) 0.82
Cross-reactivity and T-cell receptor antagonism of myelin basic protein-reactive T cells is modulated by the activation state of the antigen presenting cell. J Autoimmun (2002) 0.82
Glycogen synthase kinase-3 controls IL-10 expression in CD4(+) effector T-cell subsets through epigenetic modification of the IL-10 promoter. Eur J Immunol (2015) 0.82
Dynamic control of self-specific CD8+ T cell responses via a combination of signals mediated by dendritic cells. J Immunol (2007) 0.81
Characterization of the dominant autoreactive T-cell epitope in spontaneous autoimmune haemolytic anaemia of the NZB mouse. J Autoimmun (2002) 0.81
Base-free oxidation of glycerol using titania-supported trimetallic Au–Pd–Pt nanoparticles. ChemSusChem (2014) 0.81
Natural and induced regulatory T cells: targets for immunotherapy of autoimmune disease and allergy. Inflamm Allergy Drug Targets (2006) 0.80
Experimental autoimmune encephalomyelitis in mice expressing the autoantigen MBP 1-10 covalently bound to the MHC class II molecule I-Au. Int Immunol (2005) 0.80
Drug-polymer intermolecular interactions in hot-melt extruded solid dispersions. Int J Pharm (2012) 0.79
Natural and induced regulatory T cells. Ann N Y Acad Sci (2004) 0.79
Mechanism of synergistic interactions and its influence on drug release from extended release matrices manufactured using binary mixtures of polyethylene oxide and sodium carboxymethylcellulose. Colloids Surf B Biointerfaces (2012) 0.78
Au-Pd nanoalloys supported on Mg-Al mixed metal oxides as a multifunctional catalyst for solvent-free oxidation of benzyl alcohol. Dalton Trans (2013) 0.78
Abortive activation precedes functional deletion of CD8+ T cells following encounter with self-antigens expressed by resting B cells in vivo. Immunology (2006) 0.78
Extra-thymically induced T regulatory cell subsets: the optimal target for antigen-specific immunotherapy. Immunology (2015) 0.77
The B subunit of Escherichia coli enterotoxin helps control the in vivo growth of solid tumors expressing the Epstein-Barr virus latent membrane protein 2A. Cancer Med (2015) 0.76
Determinants of Urinary Output Response to IV Furosemide in Acute Kidney Injury: A Pharmacokinetic/Pharmacodynamic Study. Crit Care Med (2016) 0.76
A hazardous vapour trail from abattoir to neuropathy clinic. Lancet Neurol (2009) 0.75
The role of CTLA-4 in immune regulation. Immunol Lett (2007) 0.75
Uniform aligned bioconjugation of biomolecule motifs for integration within microfabricated microfluidic devices. Anal Biochem (2012) 0.75
CO bond cleavage on supported nano-gold during low temperature oxidation. Phys Chem Chem Phys (2010) 0.75
Selective oxidation of n-butanol using gold-palladium supported nanoparticles under base-free conditions. ChemSusChem (2014) 0.75
T-cell receptor degeneracy: the dog that did not bark. Adaptation of the self-reactive T-cell response to limit autoimmune disease. Mol Immunol (2004) 0.75
The reactive chemisorption of alkyl iodides at Cu(110) and Ag(111) surfaces: a combined STM and XPS study. J Phys Chem B (2005) 0.75
A facile route to model catalysts: the synthesis of Au@Pd core-shell nanoparticles on γ-Fe₂O₃ (0001). Nanoscale (2013) 0.75
The use of carbon monoxide as a probe molecule in spectroscopic studies for determination of exposed gold sites on TiO2. Phys Chem Chem Phys (2015) 0.75
Frequency effects on the surface coverage of nitrophenyl films ultrasonically grafted onto indium tin oxide. Langmuir (2011) 0.75
Deep vein thrombosis and fatal paradoxical embolism after delayed reduction of a traumatic hip dislocation. J Trauma (2008) 0.75
Spectroscopic and atomic force studies of the functionalisation of carbon surfaces: new insights into the role of the surface topography and specific chemical states. Faraday Discuss (2014) 0.75